Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02307253 · ClinicalTrials.gov registry record · NA
EUS GUIDED Transduodenal Biopsy Using the 19G Flex
A NA study of Abdominal Neoplasms, sponsored by Catholic University of the Sacred Heart.
- Completed
- Registry status
- NA
- Development phase
- 246
- Enrollment target
- 6
- Study locations
NCT02307253 is a NA study of Abdominal Neoplasms that has completed, run by Catholic University of the Sacred Heart. The registered enrollment target is 246 participants. The trial reports 6 study locations across 3 states.
The verdict
NCT02307253, a NA study of Abdominal Neoplasms, has completed, sponsored by Catholic University of the Sacred Heart.
- COMPLETED
- Registry status
- NA
- Development phase
- 246 participants
- Enrollment target
- 6
- Study locations
Study Summary
This study evaluates the feasibility, safety and accuracy of a 19 gauge (19G) needle in nitinol in the performance of endoscopic ultrasound (EUS) guided transduodenal biopsy for the acquisition of samples for histologic analysis. Patients with lesions that can be approached only from the duodenum will be prospectively enrolled.
Conditions Studied
Interventions
- DEVICE Expect™19Flex needle (Boston Scientific Corp.,Natick,MA,USA)
Study Locations (6)
Other
- Clinique du Trocadero - Paris
- AUSL Bologna Bellaria-Maggiore Hospital - Bologna
- ISMETT UPMC Italy - Palermo
- Digestive Endoscopy Unit, Universita' Cattolica del Sacro Cuore - Rome
Indiana
- Indiana Univerisity Health Medical Center - Indianapolis
Kanagawa
- Teikyo University Mizonokuchi Hospital, Departement of Gastroenterology - Kawasaki
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 246 participants |
| Start Date | 2013-06 |
| Est. Completion | 2015-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02307253
The ClinicalTrials.gov registry entry for NCT02307253 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 246 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Catholic University of the Sacred Heart, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Abdominal Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Expect™19Flex needle (Boston Scientific Corp.,Natick,MA,USA) is the first listed.
NCT02307253 reports 6 study locations spanning 3 distinct geographic areas - top geographies include Other, Indiana, Kanagawa.
Frequently Asked Questions
What is clinical trial NCT02307253 about?
NCT02307253 is a clinical study titled "EUS GUIDED Transduodenal Biopsy Using the 19G Flex". This study evaluates the feasibility, safety and accuracy of a 19 gauge (19G) needle in nitinol in the performance of endoscopic ultrasound (EUS) guided transduodenal biopsy for the acquisition of samples for histologic analysis. Patients with lesions that can be approached only from the duodenum wi...
What is the current status of trial NCT02307253?
This trial is currently completed. It is a NA study. The enrollment target is 246 participants. The study started on 2013-06. Estimated completion is 2015-10.
What conditions does trial NCT02307253 study?
This clinical trial studies the following conditions: Abdominal Neoplasms.
What interventions are being tested in trial NCT02307253?
The interventions under investigation include: Expect™19Flex needle (Boston Scientific Corp.,Natick,MA,USA) (DEVICE).
Who is sponsoring clinical trial NCT02307253?
This trial is sponsored by Catholic University of the Sacred Heart, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02307253 being conducted?
This trial has 6 study locations across Indiana, Kanagawa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.